Search results for " MIP"

showing 9 items of 9 documents

"Table 2" of "The ALICE Transition Radiation Detector: construction, operation, and performance"

2017

Most probable charge deposit signal normalised to that of minimum ionising particles as a function of $\beta\gamma$ for $\pi$, $\it{e}$ test beam (dE/dx + TR). Statistical uncertainties as vertical error bars.

$Q_{\rm MPV}/Q_{\rm MPV}^{\rm mip}$
researchProduct

"Table 1" of "The ALICE Transition Radiation Detector: construction, operation, and performance"

2017

Most probable charge deposit signal normalised to that of minimum ionising particles as a function of $\beta\gamma$ for $\pi$, $\it{e}$ test beam (dE/dx). Statistical uncertainties as vertical error bars.

$Q_{\rm MPV}/Q_{\rm MPV}^{\rm mip}$
researchProduct

"Table 5" of "The ALICE Transition Radiation Detector: construction, operation, and performance"

2017

Most probable charge deposit signal normalised to that of minimum ionising particles as a function of $\beta\gamma$ for cosmic-ray muons (dE/dx + TR). Statistical uncertainties as vertical error bars. Uncertainties in momentum and thus $\beta \gamma$ determination are drawn as horizontal error bars.

$Q_{\rm MPV}/Q_{\rm MPV}^{\rm mip}$Astrophysics::High Energy Astrophysical PhenomenaHigh Energy Physics::Experiment
researchProduct

"Table 4" of "The ALICE Transition Radiation Detector: construction, operation, and performance"

2017

Most probable charge deposit signal normalised to that of minimum ionising particles as a function of $\beta\gamma$ for cosmic-ray muons (dE/dx). Statistical uncertainties as vertical error bars. Uncertainties in momentum and thus $\beta \gamma$ determination are drawn as horizontal error bars.

$Q_{\rm MPV}/Q_{\rm MPV}^{\rm mip}$Astrophysics::High Energy Astrophysical PhenomenaHigh Energy Physics::Experiment
researchProduct

"Table 3" of "The ALICE Transition Radiation Detector: construction, operation, and performance"

2017

Most probable charge deposit signal normalised to that of minimum ionising particles as a function of $\beta\gamma$ for $\pi$, $\it{e}$ and proton in pp collisions ($\sqrt{s} = 7$ TeV). Statistical uncertainties as vertical error bars. Uncertainties in momentum and thus $\beta \gamma$ determination are drawn as horizontal error bars.

$Q_{\rm MPV}/Q_{\rm MPV}^{\rm mip}$Astrophysics::High Energy Astrophysical PhenomenaNuclear Experiment
researchProduct

Mipomersen: a lipid-lowering agent with a novel mechanism of action

2013

“...mipomersen is a ... valuable alternative to apheresis for patients with heterozygous familial hypercholesterolemia.”

inorganic chemicalsLdl cholesterolChemistryEndocrinology Diabetes and MetabolismMipomersenLipid-lowering agentnutritional and metabolic diseasesPharmacologybehavioral disciplines and activitieshumanitiesantisense oligonucleotides LDL cholesterol lipid lowering mipomersen statinsApheresisMechanism of actionAntisense oligonucleotidesmedicineLipid loweringmedicine.symptomCardiology and Cardiovascular Medicinehealth care economics and organizationsClinical Lipidology
researchProduct

Microstructure Characteristics of Unsaturated Compacted Scaly Clay

2012

Microstructure characteristics of unsaturated compacted scaly clay are investigated by MIP tests on freeze dried samples and observation of SEM photomicrographs. Effects of scale microstructure and increasing compaction stresses, and microstructure changes induced by loading and unloading paths and clay saturation are analysed.

inorganic chemicalsMaterials scienceSettore ICAR/07 - GeotecnicaCompactionWettingmicrostructure – compacted clay – wetting – loading – MIP testsComposite materialMicrostructureSaturation (chemistry)complex mixtures
researchProduct

Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk

2014

Statins are the first-line therapy in LDL-Cholesterol (LDL-C) reduction and its clinical use has contributed to significant prevention and treatment of atherosclerotic vascular disease. Yet, a significant proportion of patients remain at high risk. Recently, a number of new therapies have been developed to further lower LDL-C. These agents may provide clinical benefit on top of statin therapy in patients with high residual risk, severe hypercholesterolemia or as an alternative for patients who are intolerant to statins. We review four novel approaches based on the inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein-B100 (apoB), Cholesteryl ester transport pro…

medicine.medical_specialtySettore MED/09 - Medicina InternaApolipoprotein BHypercholesterolemiaMipomersenFamilial hypercholesterolemiaBioinformaticschemistry.chemical_compoundRisk FactorsAnacetrapibInternal medicinemedicineHumansStatins Novel LDL-C lowering drugs Mipomersen Lomitapide Anacetrapib Evacetrapib PCSK9 inhibitorsbiologybusiness.industryAnticholesteremic AgentsPCSK9nutritional and metabolic diseasesLipid Metabolismmedicine.diseaseLomitapideResidual riskEndocrinologychemistryCardiovascular Diseasesbiology.proteinlipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessEvacetrapibCurrent Atherosclerosis Reports
researchProduct

Comparison between NMR and MIP in characterizing porosity of limestone used in Cultural Heritage,

2015

Limestone with different porosity are used extensively as a sculptural and architectural stone in artistic-architectural field. As it is known, this kind of material is subjected to physico-chemical decay that involves the loss of surface and in-depth cohesion [1]. Consolidation interventions are performed in order to preserve building and decorative surfaces of architectural monuments, to reduce their degradation rate and to improve cohesion and adhesion in the stone [2]. Porosity of stone and pore size distribution are important factors to evaluate the effectiveness of a consolidation treatment and they are normally performed using a single technique such as mercury intrusion porosimetry,…

noneNMR MIP LimestoneSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)
researchProduct